CNS Drugs

, Volume 25, Issue 2, pp 171–174

The Authors’ Reply

Authors

  • Alan M. Rapoport
    • Department of NeurologyThe David Geffen School of Medicine at UCLA
  • Fred Freitag
    • Department of Family MedicineRosalind Franklin University of Medicine and Science
  • Starr H. Pearlman
    • Department of BiologyArmstrong Atlantic State University
Correspondence

DOI: 10.2165/11587780-000000000-00000

Cite this article as:
Rapoport, A.M., Freitag, F. & Pearlman, S.H. CNS Drugs (2011) 25: 171. doi:10.2165/11587780-000000000-00000

Copyright information

© Adis Data Information BV 2011